97 related articles for article (PubMed ID: 32886706)
1. SLAMF1 contributes to cell survival through the AKT signaling pathway in Farage cells.
Yoon H; Kim EK; Ko YH
PLoS One; 2020; 15(9):e0238791. PubMed ID: 32886706
[TBL] [Abstract][Full Text] [Related]
2. LMP1+SLAMF1high cells are associated with drug resistance in Epstein-Barr virus-positive Farage cells.
Yoon H; Ko YH
Oncotarget; 2017 Apr; 8(15):24621-24634. PubMed ID: 28445949
[TBL] [Abstract][Full Text] [Related]
3. Early B-cell factor 1 (EBF1) is critical for transcriptional control of SLAMF1 gene in human B cells.
Schwartz AM; Putlyaeva LV; Covich M; Klepikova AV; Akulich KA; Vorontsov IE; Korneev KV; Dmitriev SE; Polanovsky OL; Sidorenko SP; Kulakovskiy IV; Kuprash DV
Biochim Biophys Acta; 2016 Oct; 1859(10):1259-68. PubMed ID: 27424222
[TBL] [Abstract][Full Text] [Related]
4. Expression and Function of the Costimulatory Receptor SLAMF1 Is Altered in Lymphocytes From Patients With Autoimmune Thyroiditis.
Vitales-Noyola M; Ramos-Levi AM; Serrano-Somavilla A; Martínez-Hernández R; Sampedro-Nuñez M; Di Pasquale C; González-Amaro R; Marazuela M
J Clin Endocrinol Metab; 2017 Feb; 102(2):672-680. PubMed ID: 27854550
[TBL] [Abstract][Full Text] [Related]
5. Interaction of Signaling Lymphocytic Activation Molecule Family 1 (SLAMF1) receptor with Trypanosoma cruzi is strain-dependent and affects NADPH oxidase expression and activity.
Poveda C; Herreros-Cabello A; Callejas-Hernández F; Osuna-Pérez J; Maza MC; Chillón-Marinas C; Calderón J; Stamatakis K; Fresno M; Gironès N
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008608. PubMed ID: 32925918
[TBL] [Abstract][Full Text] [Related]
6. SLAMF1 is required for TLR4-mediated TRAM-TRIF-dependent signaling in human macrophages.
Yurchenko M; Skjesol A; Ryan L; Richard GM; Kandasamy RK; Wang N; Terhorst C; Husebye H; Espevik T
J Cell Biol; 2018 Apr; 217(4):1411-1429. PubMed ID: 29440514
[TBL] [Abstract][Full Text] [Related]
7. Di-(2-ethylhexyl)-phthalate interferes with T-follicular helper cell differentiation and cytokine secretion through signaling lymphocytic activation molecule family member-1.
Han Y; Wang X; Pang X; Hu M; Lu Y; Qu J; Chen G
J Immunotoxicol; 2019 Dec; 16(1):155-163. PubMed ID: 31403359
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-encoded latent membrane protein 1 activates beta-catenin signaling in B lymphocytes.
Tomita M; Dewan MZ; Yamamoto N; Kikuchi A; Mori N
Cancer Sci; 2009 May; 100(5):807-12. PubMed ID: 19309363
[TBL] [Abstract][Full Text] [Related]
9. Signaling Lymphocytic Activation Molecule Family Member 1 Engagement Inhibits T Cell-B Cell Interaction and Diminishes Interleukin-6 Production and Plasmablast Differentiation in Systemic Lupus Erythematosus.
Karampetsou MP; Comte D; Suárez-Fueyo A; Katsuyama E; Yoshida N; Kono M; Kyttaris VC; Tsokos GC
Arthritis Rheumatol; 2019 Jan; 71(1):99-108. PubMed ID: 30058241
[TBL] [Abstract][Full Text] [Related]
10. Signaling lymphocyte-activation molecule SLAMF1 augments mycobacteria BCG-induced inflammatory response and facilitates bacterial clearance.
Song T; Dong C; Xiong S
Int J Med Microbiol; 2015 Sep; 305(6):572-80. PubMed ID: 26253450
[TBL] [Abstract][Full Text] [Related]
11. Functional role of phosphatidylinositol 3-kinase/Akt pathway on cell growth and lytic cycle of Epstein-Barr virus in the Burkitt's lymphoma cell line, P3HR-1.
Mori T; Sairenji T
Virus Genes; 2006 Jun; 32(3):327-34. PubMed ID: 16732486
[TBL] [Abstract][Full Text] [Related]
12. CD150-mediated Akt signalling pathway in normal and malignant B cells.
Yurchenko M; Shlapatska LM; Romanets OL; Ganshevskiy D; Kashuba E; Zamoshnikova A; Ushenin YV; Snopok BA; Sidorenko SP
Exp Oncol; 2011 Mar; 33(1):9-18. PubMed ID: 21423089
[TBL] [Abstract][Full Text] [Related]
13. Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus.
Martin HJ; Lee JM; Walls D; Hayward SD
J Virol; 2007 Sep; 81(18):9748-58. PubMed ID: 17609264
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.
Portis T; Longnecker R
Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852
[TBL] [Abstract][Full Text] [Related]
15. Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum.
Wlodarski P; Kasprzycka M; Liu X; Marzec M; Robertson ES; Slupianek A; Wasik MA
Cancer Res; 2005 Sep; 65(17):7800-8. PubMed ID: 16140948
[TBL] [Abstract][Full Text] [Related]
16. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A
Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1.
Franken M; Devergne O; Rosenzweig M; Annis B; Kieff E; Wang F
J Virol; 1996 Nov; 70(11):7819-26. PubMed ID: 8892903
[TBL] [Abstract][Full Text] [Related]
18. PKC theta and p38 MAPK activate the EBV lytic cycle through autophagy induction.
Gonnella R; Granato M; Farina A; Santarelli R; Faggioni A; Cirone M
Biochim Biophys Acta; 2015 Jul; 1853(7):1586-95. PubMed ID: 25827954
[TBL] [Abstract][Full Text] [Related]
19. Epstein-barr virus can infect B-chronic lymphocytic leukemia cells but it does not orchestrate the cell cycle regulatory proteins.
Maeda A; Bandobashi K; Nagy N; Teramoto N; Gogolák P; Pokrovskaja K; Székely L; Björkholm M; Klein G; Klein E
J Hum Virol; 2001; 4(5):227-37. PubMed ID: 11907380
[TBL] [Abstract][Full Text] [Related]
20. SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response.
Bologna C; Buonincontri R; Serra S; Vaisitti T; Audrito V; Brusa D; Pagnani A; Coscia M; D'Arena G; Mereu E; Piva R; Furman RR; Rossi D; Gaidano G; Terhorst C; Deaglio S
J Clin Invest; 2016 Jan; 126(1):181-94. PubMed ID: 26619119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
